Mode of detection: an independent prognostic factor for women with breast cancer

J Med Screen. 2016 Jun;23(2):89-97. doi: 10.1177/0969141315604006. Epub 2015 Nov 17.

Abstract

Objectives: To investigate breast cancer survival and risk of breast cancer death by detection mode (screen-detected, interval, and detected outside the screening programme), adjusting for prognostic and predictive tumour characteristics.

Methods: Information about detection mode, prognostic (age, tumour size, histologic grade, lymph node status) and predictive factors (molecular subtypes based on immunohistochemical analyses of hormone receptor status (estrogen and progesterone) and Her2 status) were available for 8344 women in Norway aged 50-69 at diagnosis of breast cancer, 2005-2011. A total of 255 breast cancer deaths were registered by the end of 2011. Kaplan-Meier method was used to estimate six years breast cancer specific survival and Cox proportional hazard model to estimate hazard ratio (HR) for breast cancer death by detection mode, adjusting for prognostic and predictive factors.

Results: Women with screen-detected cancer had favourable prognostic and predictive tumour characteristics compared with interval cancers and those detected outside the screening programme. The favourable characteristics were present for screen-detected cancers, also within the subtypes. Adjusted HR of dying from breast cancer was two times higher for women with symptomatic breast cancer (interval or outside the screening), using screen-detected tumours as the reference.

Conclusions: Detection mode is an independent prognostic factor for women diagnosed with breast cancer. Information on detection mode might be relevant for patient management to avoid overtreatment.

Keywords: Mammography; detection mode; screening; survival; tumour characteristics.

MeSH terms

  • Aged
  • Biomarkers, Tumor / blood
  • Breast Neoplasms / blood
  • Breast Neoplasms / diagnostic imaging
  • Breast Neoplasms / mortality*
  • Breast Neoplasms / pathology
  • Early Detection of Cancer / methods*
  • Female
  • Humans
  • Mammography / statistics & numerical data*
  • Middle Aged
  • Neoplasm Metastasis
  • Norway
  • Prognosis
  • Proportional Hazards Models
  • Receptor, ErbB-2 / blood
  • Risk Factors
  • Survival Analysis

Substances

  • Biomarkers, Tumor
  • ERBB2 protein, human
  • Receptor, ErbB-2